Left ventricular hypertrabeculation/noncompaction (LVHT) is reported to be associated with embolism. This retrospective study assessed the number of strokes/embolisms in 62 patients with LVHT and in 62 control patients matched with regard to age, sex and left ventricular systolic function. The incidence of strokes or embolism was 10% in patients with LVHT and 15% in controls. LVHT by itself does not seem to be a risk factor for stroke or embolism and thus is not an indication for oral anticoagulation. However, if LVHT is associated with systolic dysfunction, oral anticoagulation should be considered.

Keywords:
Cardiomyopathy, Echocardiography, Stroke, Embolism
1.
Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R: Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation 1990;82:507–513.
2.
Stöllberger C, Finsterer J, Blazek G: Left ventricular hypertrabeculation/noncompaction and association with additional cardiac abnormalities and neuromuscular disorders. Am J Cardiol 2002;90:899–902.
3.
Sharma ND, McCullough PA, Philbin EF, Weaver WD: Left ventricular thrombus and subsequent thromboembolism in patients with severe systolic dysfunction. Chest 2000;117:314–320.
4.
Atrial Fibrillation Investigators: Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449–1457.
5.
Brainin M, Seiser A, Czvitkovits B, Pauly E: Stroke subtype is an age-independent predictor of first-year survival. Neuroepidemiology 1992;11:190–195.
6.
Finsterer J, Stöllberger C, Feichtinger H: Histological appearance of left ventricular hypertrabeculation/noncompaction. Cardiology 2002;98:162–164.
7.
Finsterer J, Stöllberger C, Kopsa W: Familial left ventricular hypertrabeculation in myotonic dystrophy type 1. Herz 2003;28:466–470.
8.
Conces DJ Jr, Ryan T, Tarver RD: Noncompaction of ventricular myocardium: CT appearance. AJR Am J Roentgenol 1991;156:717–718.
9.
Conraads V, Paelinck B, Vorlat A, Goethals M, Jacobs W, Vrints C: Isolated non-compaction of the left ventricle: A rare indication for transplantation. J Heart Lung Transplant 2001;20:904–907.
10.
Jenni R, Goebel N, Tartini R, Schneider J, Arbenz U, Oelz O: Persisting myocardial sinusoids of both ventricles as an isolated anomaly: Echocardiographic, angiographic, and pathologic anatomical findings. Cardiovasc Intervent Radiol 1986;9:127–131.
11.
Kurosaki K, Ikeda U, Hojo Y, Fujikawa H, Katsuki T, Shimada K: Familial isolated noncompaction of the left ventricular myocardium. Cardiology 1999;91:69–72.
12.
Ritter M, Oechslin E, Sütsch G, Attenhofer C, Schneider J, Jenni R: Isolated noncompaction of the myocardium in adults. Mayo Clin Proc 1997;72:26–31.
13.
Tong KL, Ding ZP: Isolated non-compaction of ventricular myocardium: A report of three cases. Ann Acad Med Singapore 2001;30:539–541.
14.
Finsterer J, Bittner R, Bodingbauer M, Eichberger H, Stöllberger C, Blazek G: Complex mitochondriopathy associated with 4mtDNA transitions. Eur Neurol 2000;44:37–41.
15.
Daimon Y, Watanabe S, Takeda S, Hijikata Y, Komuru I: Two-layered appearance of noncompaction of the ventricular myocardium on magnetic resonance imaging. Circ J 2002;66:619–621.
16.
Oechslin EN, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R: Long-term follow-up of 34 adults with isolated left ventricular noncompaction: A distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol 2000;36:493–500.
17.
Stöllberger C, Holländer I, Dimitrov L, Slany J: Influence of measurement inaccuracies on determination of left ventricular mass by M mode echocardiography. Heart 1996;75:312–313.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.